Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Market Price

152.85 

-14.30 -8.6%

as of May 06 '21

52 Week Range:

56.17 188.30


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine Specialties, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine Specialties segment offers bromine and bromine-based fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, crop protection, and custom chemistry services markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Equity (BVPS) 15.46
17.87
20.63
18.33
18.67
28.02
29.32
35.27
33.41
36.18
38.61
growth rate 15.6% 15.4% -11.2% 1.9% 50.1% 4.6% 20.3% -5.3% 8.3% 6.7%
Earnings BIT 392.10
550.62
374.59
544.43
327.40
526.51
536.63
646.62
754.97
762.63
549.84
growth rate 40.4% -32.0% 45.3% -39.9% 60.8% 1.9% 20.5% 16.8% 1.0% -27.9%
Avg.PE 15.87
10.81
17.92
12.94
32.42
19.72
18.43
12.93
28.60
12.30
44.37
growth rate -31.9% 65.8% -27.8% 150.5% -39.2% -6.5% -29.8% 121.2% -57.0% 260.7%
ROA 11.09
13.91
9.38
11.77
3.03
4.51
7.24
0.69
9.05
6.11
3.70
growth rate 25.4% -32.6% 25.5% -74.3% 48.8% 60.5% -90.5% 1,211.6% -32.5% -39.4%
ROE 24.69
29.01
18.19
23.88
8.93
14.52
18.26
1.47
19.11
14.19
9.16
growth rate 17.5% -37.3% 31.3% -62.6% 62.6% 25.8% -92.0% 1,200.0% -25.8% -35.5%
ROIC 15.98
19.89
13.79
16.68
4.89
8.02
10.50
2.13
13.63
9.38
5.81
growth rate 24.5% -30.7% 21.0% -70.7% 64.0% 30.9% -79.7% 539.9% -31.2% -38.1%
Cur. Ratio 3.70
3.38
3.66
3.40
2.94
1.13
2.90
2.06
1.69
1.58
1.22
growth rate -8.7% 8.3% -7.1% -13.5% -61.6% 156.6% -29.0% -18.0% -6.5% -22.8%
Quick Ratio 2.48
2.15
2.41
2.28
2.59
0.54
2.47
1.46
1.06
0.97
0.77
growth rate -13.3% 12.1% -5.4% 13.6% -79.2% 357.4% -40.9% -27.4% -8.5% -20.6%
Leverage 2.17
2.01
1.87
2.20
3.84
2.95
2.15
2.11
2.11
2.51
2.45
growth rate -7.4% -7.0% 17.7% 74.6% -23.2% -27.1% -1.9% 0.0% 19.0% -2.4%
Balance Sheet Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Acct.Receivable 374.70
391.57
422.82
491.96
449.27
495.55
543.11
619.39
697.46
752.45
637.83
growth rate 4.5% 8.0% 16.4% -8.7% 10.3% 9.6% 14.1% 12.6% 7.9% -15.2%
Acct.Payable 386.76
372.31
411.81
231.71
239.57
281.87
418.54
522.52
574.14
483.22
growth rate -3.7% 10.6% -43.7% 3.4% 17.7% 48.5% 24.8% 9.9% -15.8%
Cur.Assets 1,348.20
1,355.62
1,407.31
1,482.92
3,348.85
1,831.00
3,306.62
2,477.56
1,998.42
2,225.11
2,206.18
growth rate 0.6% 3.8% 5.4% 125.8% -45.3% 80.6% -25.1% -19.3% 11.3% -0.9%
Total Assets 3,068.10
3,203.82
3,437.29
3,584.80
5,223.10
9,597.95
8,161.21
7,750.77
7,581.67
9,860.86
10,450.95
growth rate 4.4% 7.3% 4.3% 45.7% 83.8% -15.0% -5.0% -2.2% 30.1% 6.0%
Cash 529.70
469.42
477.70
477.24
2,489.77
213.73
2,269.76
1,137.30
555.32
613.11
746.72
growth rate -11.4% 1.8% -0.1% 421.7% -91.4% 962.0% -49.9% -51.2% 10.4% 21.8%
Inventory 389.20
431.50
428.15
436.05
358.36
439.51
450.26
592.78
700.54
768.98
750.24
growth rate 10.9% -0.8% 1.9% -17.8% 22.7% 2.5% 31.7% 18.2% 9.8% -2.4%
Cur.Liabilities 364.20
401.18
385.01
436.36
1,139.89
1,616.69
1,140.10
1,200.93
1,183.17
1,409.00
1,801.85
growth rate 10.2% -4.0% 13.3% 161.2% 41.8% -29.5% 5.3% -1.5% 19.1% 27.9%
Liabilities 1,652.00
1,612.55
1,603.69
1,957.44
3,734.47
6,196.64
4,218.60
3,933.08
3,822.57
5,767.28
5,982.35
growth rate -2.4% -0.6% 22.1% 90.8% 65.9% -31.9% -6.8% -2.8% 50.9% 3.7%
LT Debt 851.90
749.26
686.59
1,054.31
2,223.04
3,142.16
2,121.72
1,415.36
1,393.42
2,804.03
2,709.95
growth rate -12.1% -8.4% 53.6% 110.9% 41.4% -32.5% -33.3% -1.6% 101.2% -3.4%
Equity 1,416.10
1,591.28
1,833.60
1,627.36
1,359.47
3,254.39
3,795.06
3,674.55
3,585.32
3,932.25
4,268.23
growth rate 12.4% 15.2% -11.3% -16.5% 139.4% 16.6% -3.2% -2.4% 9.7% 8.5%
Common Shares 92.00
92.00
90.00
84.00
79.00
112.00
113.00
112.00
109.00
106.00
107.00
growth rate 0.0% -2.2% -6.7% -6.0% 41.8% 0.9% -0.9% -2.7% -2.8% 0.9%
Cash Flow Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Capital Expenditures 75.48
190.57
280.87
155.35
110.58
227.65
196.65
317.70
699.99
851.80
850.48
growth rate 152.5% 47.4% -44.7% -28.8% 105.9% -13.6% 61.6% 120.3% 21.7% -0.2%
Cash Dividends 49.60
57.76
76.74
88.12
84.10
119.30
135.35
140.56
144.60
152.20
161.82
growth rate 16.5% 32.9% 14.8% -4.6% 41.9% 13.5% 3.8% 2.9% 5.3% 6.3%
Cash From OA 331.30
487.36
488.77
432.86
492.61
360.81
735.52
303.98
546.17
719.37
798.91
growth rate 47.1% 0.3% -11.4% 13.8% -26.8% 103.9% -58.7% 79.7% 31.7% 11.1%
FCF per Share 2.78
2.04
2.31
3.51
5.62
1.75
2.58
0.99
0.04
-3.02
-0.27
growth rate -26.6% 13.2% 52.0% 60.1% -68.9% 47.4% -61.6% -96.0% -100.0% 0.0%
Sale Purchase of Stock -175.90
-42.43
-576.75
2.71
0.52
9.40
8.24
growth rate 0.0% 0.0% 100.0% -80.9% 1,718.4% -12.4%
FCF 256.00
297.00
208.00
278.00
382.00
133.00
537.00
-14.00
-154.00
-132.00
-52.00
growth rate 16.0% -30.0% 33.7% 37.4% -65.2% 303.8% -100.0% 0.0% 0.0% 0.0%
Income Statement Dec '10 Dec '11 Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Dec '18 Dec '19 Dec '20
Sales 2,362.80
2,869.01
2,519.15
2,394.27
2,445.55
2,826.43
2,677.20
3,071.98
3,374.95
3,589.43
3,128.91
growth rate 21.4% -12.2% -5.0% 2.1% 15.6% -5.3% 14.8% 9.9% 6.4% -12.8%
Op.Income 401.90
392.11
325.85
435.73
327.40
526.51
536.63
646.62
754.97
762.63
549.84
growth rate -2.4% -16.9% 33.7% -24.9% 60.8% 1.9% 20.5% 16.8% 1.0% -27.9%
IBT 379.20
480.58
368.21
538.44
248.92
338.72
574.90
531.29
883.97
692.52
501.04
growth rate 26.7% -23.4% 46.2% -53.8% 36.1% 69.7% -7.6% 66.4% -21.7% -27.7%
Net Income 315.80
392.11
325.85
435.73
133.32
334.91
643.68
54.85
693.56
533.23
375.76
growth rate 24.2% -16.9% 33.7% -69.4% 151.2% 92.2% -91.5% 1,164.5% -23.1% -29.5%
EPS 3.43
4.28
3.47
4.90
1.69
3.00
5.68
0.49
6.34
5.02
3.52
growth rate 24.8% -18.9% 41.2% -65.5% 77.5% 89.3% -91.4% 1,193.9% -20.8% -29.9%
Gross Profit 741.90
954.95
898.84
850.47
770.85
916.13
970.31
1,145.27
1,234.76
1,259.48
995.55
growth rate 28.7% -5.9% -5.4% -9.4% 18.9% 5.9% 18.0% 7.8% 2.0% -21.0%
R&D 58.40
77.08
78.92
82.25
88.31
89.19
79.08
78.63
70.05
58.29
59.21
growth rate 32.0% 2.4% 4.2% 7.4% 1.0% -11.3% -0.6% -10.9% -16.8% 1.6%

Quarterly Statements

Item Name Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Earnings BIT 132.15
127.20
155.55
135.04
growth rate -3.8% 22.3% -13.2%
Balance Sheet Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Acct.Receivable 592.47
594.58
577.69
637.83
growth rate 0.4% -2.8% 10.4%
Acct.Payable 573.08
523.16
465.64
483.22
492.53
growth rate -8.7% -11.0% 3.8% 1.9%
Cur.Assets 2,155.18
2,292.41
2,227.01
2,206.18
2,009.39
growth rate 6.4% -2.9% -0.9% -8.9%
Total Assets 9,847.64
10,170.25
10,231.98
10,450.95
10,290.30
growth rate 3.3% 0.6% 2.1% -1.5%
Cash 553.23
736.70
702.07
746.72
569.86
growth rate 33.2% -4.7% 6.4% -23.7%
Inventory 853.50
851.26
828.08
750.24
685.78
growth rate -0.3% -2.7% -9.4% -8.6%
Cur.Liabilities 1,192.93
1,420.80
1,612.74
1,801.85
953.26
growth rate 19.1% 13.5% 11.7% -47.1%
Liabilities 5,806.11
5,964.09
5,906.60
5,982.35
growth rate 2.7% -1.0% 1.3%
LT Debt 3,046.51
3,073.57
2,881.96
2,709.95
growth rate 0.9% -6.2% -6.0%
Equity 3,878.00
4,024.47
4,124.88
4,268.23
5,746.38
growth rate 3.8% 2.5% 3.5% 34.6%
Common Shares 1.06
1.06
1.07
1.07
1.17
growth rate 0.1% 0.1% 0.4% 9.2%
Cash Flow Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Capital Expenditures 214.53
204.46
202.38
229.11
growth rate -4.7% -1.0% 13.2%
Cash Dividends 38.98
40.93
40.93
40.98
growth rate 5.0% 0.0% 0.1%
Cash From OA 155.05
52.86
253.80
337.20
157.95
growth rate -65.9% 380.1% 32.9% -53.2%
Sale Purchase of Stock
growth rate
FCF -59.48
-151.60
51.42
108.09
growth rate 0.0% 100.0% 110.2%
Income Statement Mar '20 Jun '20 Sep '20 Dec '20 Mar '21
Sales 738.85
764.05
746.87
879.15
829.29
growth rate 3.4% -2.3% 17.7% -5.7%
Op.Income 132.15
127.20
155.55
135.04
growth rate -3.8% 22.3% -13.2%
IBT 142.08
119.19
147.70
92.08
growth rate -16.1% 23.9% -37.7%
Net Income 107.20
85.62
98.30
84.64
95.68
growth rate -20.1% 14.8% -13.9% 13.1%
EPS
growth rate
Gross Profit 242.72
233.36
254.06
265.42
growth rate -3.9% 8.9% 4.5%
R&D 16.10
14.21
13.53
15.38
14.64
growth rate -11.7% -4.8% 13.6% -4.8%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (25.88)

YOY Growth Grade:

E (29.10)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 48.12 43.42 33.88
EPS / Growth 9.3% 3.52 25.6%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 10.2%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 9.3% 9.7% 9.7%
Future PE 18.62 33.82 33.82
Future EPS 8.57 8.91 8.91
Value Price
MOS %
39.46
-74.2%
74.47
-51.3%
74.47
-51.3%
MOS Price 19.73 37.24 37.24
IRT 17.37 17.01 17.01

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.